Central venous disease in hemodialysis patients: prevalence, etiology and treatment

Area of Science:

• Vascular Surgery
• Nephrology
• Interventional Radiology

Background:

• Central venous occlusive disease is a prevalent complication in hemodialysis patients.
• Existing treatments like angioplasty, bare metal stents, and bypass surgery offer suboptimal long-term patency.
• Repetitive interventions are often necessary due to poor outcomes of current therapies.

Purpose of the Study:

• To review the current treatment landscape for central venous occlusive disease in hemodialysis patients.
• To evaluate the emerging role of covered stents as a potential treatment option.
• To emphasize the importance of preventative strategies in managing this condition.

Main Methods:

• Literature review of existing treatment modalities for central venous occlusive disease.
• Discussion of percutaneous balloon angioplasty, bare metal stents, and surgical bypass.
• Exploration of preliminary data on covered stents for central venous stenosis and obstruction.

Main Results:

• Current treatment options demonstrate poor long-term patency rates.
• Covered stents are a recent development with limited published data.
• Further randomized controlled trials are required to compare different treatment efficacies.

Conclusions:

• There is a critical need for improved long-term solutions for central venous occlusive disease in hemodialysis.
• Covered stents show promise but require more extensive research and comparative studies.
• Preventing central venous access and interventions is paramount for long-term patient management.